John M. Venditti
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 13
- Retinoids in leukemia and cellular processes 5
- Enzyme function and inhibition 5
- Oncology 20
- Cancer Treatment and Pharmacology 9
- Co-authors
- Abraham Goldin (48 shared papers)Nathan Mantel (27 shared papers)Stewart R. Humphreys (27 shared papers)I Kline (21 shared papers)A Goldin (11 shared papers)Saul A. Schepartz (2 shared papers)Michaele C. Christian (1 shared paper)Edward A. Sausville (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (14 papers)Science (6 papers)Nature (3 papers)Cancer (2 papers)Chemotherapy (2 papers)
- Partner nations
- United StatesMalaysiaIndia
In The Last Decade
John M. Venditti
88 papers receiving 2.3k citations
John M. Venditti's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.0k
- Cancer Research 397
- Biotechnology 215
- Hematology 208
- Molecular Biology 1.1k
Countries citing papers authored by John M. Venditti
This map shows the geographic impact of John M. Venditti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Venditti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Venditti more than expected).
Fields of papers citing papers by John M. Venditti
This network shows the impact of papers produced by John M. Venditti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Venditti. The network helps show where John M. Venditti may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Venditti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials Hit paper breakdown → | 2001 | 621 |
| 2 | Application of a human tumor colony-forming assay to new drug screening. | 1985 | 179 |
| 3 | 1981 | 154 | |
| 4 | 1966 | 88 | |
| 5 | 1954 | 76 | |
| 6 | Preclinical drug development: rationale and methods. | 1981 | 70 |
| 7 | 1984 | 61 | |
| 8 | 1973 | 56 | |
| 9 | Effect of delayed administration of citrovorum factor on the antileukemic effectiveness of aminopterin in mice. | 1954 | 52 |
| 10 | Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue. | 1988 | 49 |
| 11 | 1964 | 48 | |
| 12 | 1956 | 46 | |
| 13 | 1971 | 46 | |
| 14 | Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo. | 1974 | 46 |
| 15 | 1959 | 44 | |
| 16 | Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. | 1987 | 44 |
| 17 | Estimation of the antileukemic potency of the antimetabolite aminopterin, administered alone and in combination with citrovorum factor or folic acid. | 1953 | 42 |
| 18 | 1972 | 41 | |
| 19 | 1963 | 40 | |
| 20 | Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma. | 1975 | 39 |
About John M. Venditti
John M. Venditti is a scholar working on Molecular Biology, Oncology, Immunology, Public Health, Environmental and Occupational Health and Genetics, having authored 91 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (14 papers), Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), T-cell and Retrovirus Studies (6 papers), Retinoids in leukemia and cellular processes (5 papers), Enzyme function and inhibition (5 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (397 citations), Biotechnology (215 citations), Hematology (208 citations) and Molecular Biology (1.1k citations). John M. Venditti has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include Abraham Goldin, Nathan Mantel, Stewart R. Humphreys, I Kline, A Goldin, Saul A. Schepartz, Michaele C. Christian, Edward A. Sausville, J I Johnson and Shannon Decker. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Science, Nature, Cancer and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.